Rickard Kathleen A. sold VRNA
March 12, 2025 · Form 4 insider transaction
Rickard Kathleen A. sold 79,264 shares of Verona Pharma Plc at $8.35 per share, a transaction worth $661.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.; The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted on December 11, 2024.; The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $7.9975 to $8.5513 per Ordinary Share, inclusive (or $63.98 to $68.41 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.; Consists of (i) 722,488 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 90,311 ADSs); and (ii) 1,886,488 Ordinary Shares underlying 235,811 ADSs.